Diabetes Drug Ozempic Back in Supply in US After Shortage

Novo Nordisk's best-selling diabetes treatment drug Ozempic is back on the shelves in the United States after months of shortage.
Reuters Health Information

source https://www.medscape.com/viewarticle/989805?src=rss